Grant: China-Canada Joint Health Research Initiative
McMaster University
$150,000.00
Role of gut bacterial derived peptidoglycan in the induction of immune inflammation in the intestine
FY 2009-10
Summary
Intestinal inflammation compromises human health and social economy. Chronic intestinal inflammation, such as inflammatory bowel disease (IBD) and chronic diarrhea, causes significant morbidity in general populations. The incidence rate of IBD is estimated at 0.5% in Canada, which has a substantial negative impact on human health and social economy and has emerged as one of the major health problems. Current therapeutic remedies for IBD are not satisfactory. Therefore, there is an urgent need for novel and more effective therapeutic approaches for IBD. On the other hand, elucidation of the underlying mechanisms of IBD also contributes to the development of novel therapeutic strategies.
Bacterium-derived factors are involved in the pathogenesis of intestinal inflammation. The most commonly accepted etiology of IBD is a loss of tolerance to luminal microflora. The distal ileum and colon are the areas with the highest bacterial concentrations in the body and represent the sites of inflammation in IBD Sartor . Rats raised in germ-free conditions do not develop colitis Sellon . Colonization of these animals with bacteria rapidly induces gut inflammation. These observations support the notion that IBD is mediated by aberrant immune responses directed at enteric microflora Packey; gut microbial components such as peptidoglycan (PGN) have a close relation with the pathogenesis of intestinal inflammation.
The proposed study will use a set of updated research technique to take further insight into the mechanism by which gut microbial components in the induction of intestinal immune inflammation that include: (1) Examination of intestinal epithelial innate defense mechanism in IBD patients; (2) investigate into the mechanism by which microbial products impair the innate defense mechanism in the gut and (3) restoration of the impaired innate defense mechanism in the intestine with immune inflammation.
Department
Program
China-Canada Joint Health Research Initiative
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
199931
Name
Yang Pingchang
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
Role of gut bacterial derived peptidoglycan in the induction of immune inflammation in the intestine
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Bacteria; Infection; Inflammation; Intestine
Abstract
Intestinal inflammation compromises human health and social economy. Chronic intestinal inflammation, such as inflammatory bowel disease (IBD) and chronic diarrhea, causes significant morbidity in general populations. The incidence rate of IBD is estimated at 0.5% in Canada, which has a substantial negative impact on human health and social economy and has emerged as one of the major health problems. Current therapeutic remedies for IBD are not satisfactory. Therefore, there is an urgent need for novel and more effective therapeutic approaches for IBD. On the other hand, elucidation of the underlying mechanisms of IBD also contributes to the development of novel therapeutic strategies.
Bacterium-derived factors are involved in the pathogenesis of intestinal inflammation. The most commonly accepted etiology of IBD is a loss of tolerance to luminal microflora. The distal ileum and colon are the areas with the highest bacterial concentrations in the body and represent the sites of inflammation in IBD Sartor . Rats raised in germ-free conditions do not develop colitis Sellon . Colonization of these animals with bacteria rapidly induces gut inflammation. These observations support the notion that IBD is mediated by aberrant immune responses directed at enteric microflora Packey; gut microbial components such as peptidoglycan (PGN) have a close relation with the pathogenesis of intestinal inflammation.
The proposed study will use a set of updated research technique to take further insight into the mechanism by which gut microbial components in the induction of intestinal immune inflammation that include: (1) Examination of intestinal epithelial innate defense mechanism in IBD patients; (2) investigate into the mechanism by which microbial products impair the innate defense mechanism in the gut and (3) restoration of the impaired innate defense mechanism in the intestine with immune inflammation.
Competitiondate
201003
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yang, Pingchang; Liu, Zhanju
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $150,000~ $0~